Lamivudine Prophylaxis for Hepatitis B Virus Infection After Lung Transplantation

Annals of Thoracic Surgery

Volumn 81, Issue 5, 2006, Pages 1851-1852

  Shitrit, Ariella Bar Gil ^a   Kramer, Mordechai R ^b   Bakal, Ilana ^b   Morali, Gilles ^a   Ari, Ziv Ben ^b   Shitrit, David ^b  

^a SHAARE ZEDEK MEDICAL CENTER   (Israel)

^b RABIN MEDICAL CENTER   (Israel)

Author keywords

[No Author keywords available]

Indexed keywords

ADEFOVIR DIPIVOXIL; ALANINE AMINOTRANSFERASE; BIOLOGICAL MARKER; HEPATITIS B ANTIBODY; HEPATITIS B CORE ANTIBODY; HEPATITIS B SURFACE ANTIGEN; LAMIVUDINE; VIRUS DNA; HEPATITIS B CORE ANTIGEN; RNA DIRECTED DNA POLYMERASE INHIBITOR;

ABSENCE OF SIDE EFFECTS; ADOLESCENT; ADULT; AGED; ALANINE AMINOTRANSFERASE BLOOD LEVEL; ARTICLE; DONOR; DRUG SAFETY; FOLLOW UP; GRAFT RECIPIENT; HEPATITIS B; HEPATITIS B VIRUS; HUMAN; INFECTION PREVENTION; LIVER DYSFUNCTION; LUNG TRANSPLANTATION; MAJOR CLINICAL STUDY; POSTOPERATIVE CARE; PRIORITY JOURNAL; SCREENING; SEROLOGY; SURGICAL PATIENT; VIRUS REACTIVATION; VIRUS RESISTANCE; VIRUS STRAIN; DISEASE TRANSMISSION; IMMUNOLOGY; MIDDLE AGED;

ADOLESCENT; ADULT; AGED; HEPATITIS B; HEPATITIS B CORE ANTIGENS; HEPATITIS B SURFACE ANTIGENS; HUMANS; LAMIVUDINE; LUNG TRANSPLANTATION; MIDDLE AGED; REVERSE TRANSCRIPTASE INHIBITORS;

EID: 33646846613     PISSN: 00034975     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.athoracsur.2005.12.026     Document Type: Article

References (17)

1. Lee W.M. Hepatitis B virus infection. N Engl J Med 337 (1997) 1733-1745
2. Degos F., Lugassy C., Degott C., et al. Hepatitis B virus and hepatitis B-related viral infection in renal transplant recipients. a prospective study of 90 patients. Gastroenterology 94 (1988) 151-156
3. De Villa V.H., Chen Y.S., and Chen C.L. Hepatitis B core antibody-positive grafts. recipients's risk. Transplantation 75 Suppl (2003) S49-S53
4. Wachs M.E., Amend W.J., Ascher N.L., et al. The risk of transmission of hepatitis B from HBsAg (-), HBcAb (+), HBIgM (-) organ donors. Transplantation 59 (1995) 230-234
5. Dickson R.C., Everhart J.E., Lake J.R., et al. Transmission of hepatitis B by transplantation of livers from donors positive for antibody to hepatitis B core antigen. The national institute of diabetes and digestive and kidney diseases liver transplantation database. Gastroenterology 113 (1997) 1668-1674
6. Yu A.S., Vierling J.M., Colqubhoun S.D., et al. Transmission of hepatitis B infection from hepatitis B core antibody-positive liver allografts is prevented by lamivudine therapy. Liver Transpl 7 (2001) 513-517
7. Dodson S.F. Prevention of de novo hepatitis B infection after liver transplantation with allografts from hepatitis B core antibody positive donors. Clin Transplant 14 Suppl 2 (2000) 20-24
8. Nery J.R., Nery-Avila C., Reddy K.R., et al. Use of liver grafts from donors positive for antihepatitis B-core antibody in the era of prophylaxis with hepatitis B immunoglobulin and lamivudine. Transplantation 75 (2003) 1179-1186
9. Fabrizi F., Dulai G., Dixit V., et al. Lamivudine for the treatment of hepatitis B virus-related liver disease after renal transplantation. meta-analysis of clinical trials. Transplantation 77 (2004) 859-864
10. Loss G.E., Mason A.L., Nair S., et al. Does lamivudine prophylaxis eradicate persistent HBV-DNA allografts derived from anti-HBc-positive donors?. Liver Transpl 9 (2003) 1258-1264
11. De Villa V.H., Chen Y.S., and Chen C.L. Hepatitis B core antibody-positive grafts:recipient's risk. Transplantation 75 Suppl (2003) S49-S53
12. Alavian S.M., Hajarizadeh B., and Einollahi B. Efficacy and safety of lamivudine for treatment of chronic hepatitis B in renal allograft recipients. Transplant Proc 35 (2003) 2687-2688
13. Grossi P., Gasperina D., Furino M., et al. Lamivudine treatment for HBV infection following thoracic organ transplantation. Transplant Proc 33 (2001) 1576-1578
14. Wang S.S., Chou N.K., Ko W.J., et al. Heart transplantation using donors positive for hepatitis. Transplant Proc 36 (2004) 2371-2373
15. Liu C.J., Lai M.Y., Lee P.H., et al. Lamivudine treatment for hepatitis B reactivation in BsAG carriers after organ transplantation. a 4-years experience. J Gastroenterol Hepatol 16 (2001) 1001-1008
16. Ko W.J., Chou N.K., Hsu R.B., et al. Hepatitis B virus infection in heart transplant recipients in a hepatitis B endemic area. J Heart Lung Transplant 20 (2001) 865-875
17. Pinney S.P., Cheema F.H., Hammond K., Chen J.M., Edwards N.M., and Mancini D. Acceptable recipient outcomes with the use of hearts from donors with Hepatitis B core antibodies. J Heart Lung Transplant 24 (2005) 34-37